Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors.

Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors.

Item
http://www.wikidata.org/entity/Q35674875
New drugs in prostate cancerArginine deiminase expressed in vivo, driven by human telomerase reverse transcriptase promoter, displays high hepatoma targeting and oncolytic efficiency.Drug-induced amino acid deprivation as strategy for cancer therapy.Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1-Deficient Thoracic Cancers.Arginine dependence of tumor cells: targeting a chink in cancer's armor.Altered metabolite levels in cancer: implications for tumour biology and cancer therapy.The Metabolic Phenotype of Prostate Cancer.Development and evaluation of a host-targeted antiviral that abrogates herpes simplex virus replication through modulation of arginine-associated metabolic pathways.Arginine auxotrophic gene signature in paediatric sarcomas and brain tumours provides a viable target for arginine depletion therapies.A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma.The arginine metabolome in acute lymphoblastic leukemia can be targeted by the pegylated-recombinant arginase I BCT-100.Argininosuccinate lyase interacts with cyclin A2 in cytoplasm and modulates growth of liver tumor cells.How Tumor Cells Choose Between Epithelial-Mesenchymal Transition and Autophagy to Resist Stress-Therapeutic Implications.Linking cellular metabolism and metabolomics to risk-stratification of prostate cancer clinical aggressiveness and potential therapeutic pathways
P2860

Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors.

Item
http://www.wikidata.org/entity/Q35674875
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Phase I Trial of Arginine Depr ...... vanced Malignant Solid Tumors.
@ast
Phase I Trial of Arginine Depr ...... vanced Malignant Solid Tumors.
@en
type
label
Phase I Trial of Arginine Depr ...... vanced Malignant Solid Tumors.
@ast
Phase I Trial of Arginine Depr ...... vanced Malignant Solid Tumors.
@en
prefLabel
Phase I Trial of Arginine Depr ...... vanced Malignant Solid Tumors.
@ast
Phase I Trial of Arginine Depr ...... vanced Malignant Solid Tumors.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Phase I Trial of Arginine Depr ...... vanced Malignant Solid Tumors.
@en
P2093
P2860
P304
P31
P356
10.1158/1078-0432.CCR-14-2610
P407
P433
P478
P50
P577
P698
P921
P932